Global Continuous Glucose Monitoring (CGM) Systems Market- Market Overview:

The global Continuous Glucose Monitoring (CGM) Systems Market is expected to grow from USD 4.06 billion in 2022 to USD 10.05 billion by 2030, at a CAGR of 12% during the Projection period 2023-2030. The growth of the Continuous Glucose Monitoring (CGM) Systems Market is mainly driven by the increase in sugar intake among people.

A novel method for continuously monitoring blood glucose, often known as blood sugar, in real-time is called continuous glucose monitoring. A sensor that is implanted under the skin, typically on the arm or abdomen, is used in the CGM method, which was developed as a result of technological developments in the healthcare industry. It is a tiny sensor that collects information on the glucose concentrations in the intercellular fluid. Every few minutes, the sensor can gather data and wirelessly transfer it to a monitor via the transmitter. CGM is a strategy that includes a sensor, transmitter, and data display monitor as a result. Some CGMs can be linked to an insulin pump, which both produces and administers insulin. When the glucose level rises or falls, CGM devices continuously monitor it and warn the user. The output information from these systems is downloaded to a computer or another smart device for additional examination. Such information is utilized to aid in the diagnosis of the patient and to offer a more specialized course of treatment. With the use of CGMs, diabetic patients can efficiently control their blood sugar levels, experience fewer low blood sugar situations, and, in recent years, prevent disease consequences including chronic illnesses, renal issues, eye issues, etc.

Sample Request: - Global Continuous Glucose Monitoring (CGM) Systems Market

Market Dynamics:

Drivers:                          

• Rising Prevalence of Diabetes

The rising prevalence of diabetes and the growing number of elderly people who are diabetic are major market drivers. The market for Continuous Glucose Monitoring (CGM) devices is also being driven by new product introductions, government initiatives, and rising awareness of diabetes preventative care. The government agencies' reduced restrictions and published guidelines for the use of home-use glucose meters or CGMs in hospital settings are credited with increasing demand for continuous glucose monitoring devices during the COVID-19 epidemic. The Dexcom G6 and Abbott FreeStyle Libre are two CGMs that are permitted for usage in hospitals.

Restraints:                                             

• High Price

The high price of continuous glucose monitoring systems suggests a negative impact on the early market development for such systems. Patients are responsible for the expenses of blood glucose monitors and test strips in poor nations like India. The percentage of people with undiagnosed diabetes in Asiatic nations is 55%, according to the International Diabetes Federation in 2021. Regarding the payment for glucose monitoring devices and the supplies they require, there is no established pattern. Additionally, it has been noted that the number of testing strips given to each patient annually in certain emerging nations, such as Canada and Europe, is constrained by the patient's treatment regimen.

Opportunities:

• Rise in Awareness

The market is anticipated to display an opportunity-seeking mindset as a result of people's attention to their health. They are now able to continuously check blood glucose levels because of technological advancements in continuous blood glucose monitoring equipment. They also show glucose direction and extra statistics on monitors, giving users crucial information to support managing diabetes. The considerable increase in the number of elderly people with diabetes will further fuel the growth. According to research from the National Institute of Diabetes and Digestive and Kidney Diseases (US), around 40% of adults with diabetes are over 65, and that number is expected to quadruple to 1.5 billion by 2050.

Challenges:

• Expenses Related to CGMs

Medical decisions should not be based on CGMs; traditional finger-prick testing should still be used to verify CGM accuracy. Furthermore, not all insurance plans presently cover the costs of a CGM, and CGMs are significantly more expensive than conventional glucose metres. These elements impede the market's expansion.

Segmentation Analysis:

The global Continuous Glucose Monitoring (CGM) Systems Market has been segmented based on component, end-user, and region.

By Component

The component segment is Sensors, Transmitters, and Receivers. The sensors segment led the largest share of the Continuous Glucose Monitoring (CGM) Systems Market with a market share of around 39% in 2022. The most complex component of CGM devices, the sensors are made of a metallic filament that is thinner than a needle and is injected into the fatty layer immediately beneath the skin. The technology utilised in transmitters and receivers and sensors is slightly different. These elements measure blood sugar levels using glucose oxidase. In the sensor, platinum combines with glucose oxidase to produce hydrogen peroxidase, which then produces an electrical signal that is sent to the transmitter.

By End-User

The end-user segment is Home Care, Hospitals, and Others. The hospitals segment led the largest share of the Continuous Glucose Monitoring (CGM) Systems Market with a market share of around 40% in 2022. The use of CGM devices in hospitals and other healthcare facilities to monitor patients with diabetes Mellitus blood sugar levels is one of the factors fueling this expansion. The National Center for Biotechnology Information reports that CGM systems outperform Self-monitoring Blood Glucose (SMBG) devices in clinical investigations including gestational diabetes mellitus. Further boosting product acceptance in the hospital end-use category will be the release of technologically sophisticated diabetes treatment devices.

Global Continuous Glucose Monitoring (CGM) Systems Market - Sales Analysis.

The sale of the Continuous Glucose Monitoring (CGM) Systems Market expanded at a CAGR of 9% from 2016 to 2022.

Over the past 15 years, there have been several improvements made to glucose monitoring systems, such as highly advanced blood glucose meters, non-invasive glucose monitoring (NGM) devices, and continuous glucose monitoring systems (CGMS). Because these methods may identify large drops in glycated hemoglobin (HbA1c) levels in persons with type I diabetes, they have led to significant advancements in the management of diabetes. The majority of NGM-based continuous glucose monitoring systems are non-invasive. Diabetes is spreading throughout the world. According to the International Diabetes Federation, 240 million persons (or one in two) still do not have a diabetes diagnosis, and 783 million are predicted to have a diagnosis by the year 2045.

People are selecting continuous blood glucose monitors for immediate diagnosis, which will cause the market to expand in the anticipated time frame and present enormous potential for the main players to develop more technologically sophisticated products to expand their product lines. It has been noted that the market for continuous glucose monitoring has experienced a tremendous increase since the epidemic. Although the American Diabetes Association claims that there is insufficient research to conclusively show that diabetics are more prone to contract COVID-19, there is sufficient information to show that diabetics who did contract COVID-19 experienced some major health consequences. This element will also fuel the market expansion of systems for continuous glucose monitoring.

Thus, owing to the aforementioned factors, the global Continuous Glucose Monitoring (CGM) Systems Market is expected to grow at a CAGR of 12% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the continuous glucose monitoring (CGM) systems market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region dominated the continuous glucose monitoring (CGM) systems market and held a 39% share of the market revenue in 2022.

• The North America region witnessed a major share. Increasing diabetes cases, national government initiatives to manage the condition more effectively, expanding use of alternative and novel technologies, and the presence of major market players are some of the factors propelling market expansion in the North American area. In a research study by Sandip Garg et al., which was published in the Diabetes Technology & Therapeutics Journal in March 2021, it was determined that the COVID-19 pandemic had exposed weaknesses and put an extreme financial strain on almost every component of the American healthcare system. An illustration of how the pandemic and the increased significance of technology in transforming care delivery collide is diabetes care.
• Asia-Pacific is anticipated to experience significant growth during the Projection period. Compared to other parts of the world, the Asia-Pacific region is seeing an increase in the number of diabetic patients. India and China have the most diabetic patients worldwide, according to the International Diabetes Federation. Type I and type II diabetes have become more common as a result of rising socioeconomic inequality and the rise in obesity occurrences.

Global Continuous Glucose Monitoring (CGM) Systems Market - Country Analysis:

• Germany

Germany's continuous glucose monitoring (CGM) systems market size was valued at USD 0.30 billion in 2022 and is expected to reach USD 0.74 billion by 2030, at a CAGR of 12.1% from 2023 to 2030.

This market is expanding as a result of the rising incidence and prevalence of diabetes around the region as well as the expanding use of continuous glucose monitoring devices. The need for continuous glucose monitoring device systems is also increasing due to aging populations and long-term technological advancements in the field.

• China

China’s continuous glucose monitoring (CGM) systems market size was valued at USD 0.30 billion in 2022 and is expected to reach USD 0.76 billion by 2030, at a CAGR of 12.5% from 2023 to 2030.

This is brought about by a growth in the number of patients who are insulin-dependent and an increase in the elderly population. People have also expressed interest in purchasing further cutting-edge, unique goods to control their blood sugar levels. As a result, the major firms are working very hard to launch new glucose monitoring systems on the market. It is therefore anticipated that the market will gain from this.

• India

India's continuous glucose monitoring (CGM) systems market size was valued at USD 0.234 billion in 2022 and is expected to reach USD 0.59 billion by 2030, at a CAGR of 12.4% from 2023 to 2030.

Economic expansion and the growing desire of the diabetic population to keep a close eye on blood sugar levels are driving up demand for and growth in the market for continuous glucose monitoring systems. Healthcare startup BlueSemi unveiled the EVYA non-invasive glucometer on September 22, 2022, which can deliver precise results without the use of needles or pricks.

Key Industry Players Analysis:

To increase their market position in the global Continuous Glucose Monitoring (CGM) Systems Market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.

• Medtronic
• Hoffmann-La Roche Ltd.
• Dexcom, Inc.
• Ypsomed
• Abbott
• Novo Nordisk A/S
• GlySens, Inc.

Latest Development:

• In November 2020, Abbott will launch FREESTYLE® LIBRE in India to give real-time glucose monitoring updates without invasive finger probes.
• On August 24, 2021, Smart Meter announced the launch of the iGlucose monitor for managing gestational diabetes.
• In March 2022, The Ontario (Canada State) provincial government announced a comprehensive continuous glucose monitoring (CGM) payment programme for qualified citizens with type 1 diabetes.
• In December 2021, The U.S. Centers for Medicare & Medicaid Services (CMS) stated that all continuous glucose monitors (CGMs), including adjunctive and non-adjunctive CGMs, would henceforth be covered under Medicare. This includes CGMs that connect to insulin pumps made by Medtronic. The revised regulation became effective in February 2022.

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	12%
Market Size	4.06 billion in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Component, By End-User, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Medtronic, F. Hoffmann-La Roche Ltd., Dexcom, Inc., Ypsomed, Abbott, Novo Nordisk A/S, and GlySens, Inc.
By Component	Sensors Transmitters Receivers
By End-User	Home Care Hospitals Others
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Continuous Glucose Monitoring (CGM) Systems Market  By Component :

• Sensors
• Transmitters
• Receivers

Global Continuous Glucose Monitoring (CGM) Systems Market By End-User:

• Home Care
• Hospitals
• Others

Global Continuous Glucose Monitoring (CGM) Systems Market By Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- Entering high-tax nations will have a direct impact on the Continuous Glucose Monitoring (CGM) Systems Market's profitability. Exports are hampered by high taxes, which also affect international trade. The market for Continuous Glucose Monitoring (CGM) Systems can participate in calls with low taxes and benefit from significant revenues that can be utilized to finance R&D projects. The organization may also look into the tax laws that are pertinent to the business in order to understand the priorities and interests of the host government in rising industries. High trade barriers might exacerbate the current economic situation by harming exports and relationships with international trading partners. Furthermore, if the government of the country under scrutiny does not take seriously its obligation to protect the intellectual property rights of commercial enterprises.

Economical Factors- The GDP growth rate will determine if the Continuous Glucose Monitoring (CGM) Systems Market can achieve its long-term growth goals. A high GDP also suggests that consumers have higher purchasing power for the products being supplied. High unemployment is a sign that there is surplus labor available at relatively lower wages. Operating in such a market enables the gummy vitamin industry to cut production costs. The corporation should carefully consider the interest rate and how it influences borrowing capacity and investment mindset. The market for Continuous Glucose Monitoring (CGM) Systems will have greater development potential because to the high-interest rate, which will encourage an investment-friendly mentality. Finally, changes in exchange rates may have an effect on both profitability and international trade.

Social Factor- Changes in demographic patterns, such as population aging, migration trends, and socioeconomic features, are crucial for global market places like the Continuous Glucose Monitoring (CGM) Systems Market. With the aid of research on the demographic factors, the appropriate market segment or sectors with considerable development potential may be chosen by the Continuous Glucose Monitoring (CGM) Systems Market. Additionally, migration affects the company and marketing strategy. Understanding how people feel about migration as a whole is important for the Continuous Glucose Monitoring (CGM) Systems Market since it can influence companies' ability to hire foreign management in the host country.

Technological Factors- The Continuous Glucose Monitoring (CGM) Systems Market must carefully examine recent technical advancements if it is to remain competitive. It's essential to keep an eye on the 5G's potential to boost productivity by enhancing user experience, speed, and access. These technical developments have the potential to radically change an industry and rewrite the rules for market actors' success. The technology's level of development and maturity in the pertinent industry must also be considered. When the Continuous Glucose Monitoring (CGM) Systems Market enters markets where technological development has yet to reach maturity, it might increase its market share by focusing on new technological developments.

Environmental Factors- More people are choosing to use green or eco-friendly products. To win the trust of stakeholders, the Continuous Glucose Monitoring (CGM) Systems Market can embrace the opportunity and execute green business methods. Due to regulatory organisations' emphasis on assuring compatibility with environmental requirements, priorities for product innovation are changing. The promotion of the eco-friendliness of the products in the Continuous Glucose Monitoring (CGM) Systems Market must come before traditional value propositions. The market for Continuous Glucose Monitoring (CGM) Systems may cause a negative response from the press, environmental protection groups, consumers, and the general public due to its excessive resource use. Continuous Glucose Monitoring (CGM) Systems Market. must examine the nation's unique environmental legislation to find out which resources (such as water, electricity, etc.) are considered to be uncommon or which species are considered to be endangered, whose overuse can pose problems for the organisation.

Legal Factors- The Continuous Glucose Monitoring (CGM) Systems Market is necessary to follow employee/labor health and safety criteria since some countries have strict laws protecting workplace safety. The Continuous Glucose Monitoring (CGM) Systems Market has a moral and ethical obligation to provide a secure working environment for all of its employees. Similar to the above, when developing human resource practices, anti-discrimination laws (such as equal employment opportunity laws) must also be carefully taken into account because discriminatory lawsuits against employers harm an organization's reputation and impair its ability to recruit and retain talent.

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Component
     • 3.2. Market Attractiveness Analysis By End-User
     • 3.3. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Rising Prevalence of Diabetes
   • 3. Restraints
     • 3.1. High Price
   • 4. Opportunities
     • 4.1. Rise in Awareness
   • 5. Challenges
     • 5.1. Expenses Related to CGMs

6. Global Continuous Glucose Monitoring (CGM) Systems Market Analysis and Projection, By Component
   • 1. Segment Overview
   • 2. Sensors
   • 3. Transmitters
   • 4. Receivers
7. Global Continuous Glucose Monitoring (CGM) Systems Market Analysis and Projection, By End-User
   • 1. Segment Overview
   • 2. Home Care
   • 3. Hospitals
   • 4. Others
8. Global Continuous Glucose Monitoring (CGM) Systems Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

9. Global Continuous Glucose Monitoring (CGM) Systems Market-Competitive Landscape
   • 1. Overview
   • 2. Market Share of Key Players in the Continuous Glucose Monitoring (CGM) Systems Market
     • 2.1. Global Company Market Share
     • 2.2. North America Company Market Share
     • 2.3. Europe Company Market Share
     • 2.4. APAC Company Market Share
   • 3. Competitive Situations and Trends
     • 3.1. Technology Launches and Developments
     • 3.2. Partnerships, Collaborations, and Agreements
     • 3.3. Mergers & Acquisitions
     • 3.4. Expansions

10. Company Profiles
    • Medtronic
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Technology Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • Hoffmann-La Roche Ltd.
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Technology Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Dexcom, Inc.
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Technology Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Ypsomed
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Technology Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • Abbott
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Technology Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • Novo Nordisk A/S
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Technology Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • GlySens, Inc.
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Technology Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis

List of Table

1. Global Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
2. Global Sensors, Continuous Glucose Monitoring (CGM) Systems Market, By Region, 2023–2030 (USD Billion)
3. Global Transmitters, Continuous Glucose Monitoring (CGM) Systems Market, By Region, 2023–2030 (USD Billion)
4. Global Receivers, Continuous Glucose Monitoring (CGM) Systems Market, By Region, 2023–2030 (USD Billion)
5. Global Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
6. Global Home Care, Continuous Glucose Monitoring (CGM) Systems Market, By Region, 2023–2030 (USD Billion)
7. Global Hospitals, Continuous Glucose Monitoring (CGM) Systems Market, By Region, 2023–2030 (USD Billion)
8. Global Others, Continuous Glucose Monitoring (CGM) Systems Market, By Region, 2023–2030 (USD Billion)
9. Global Continuous Glucose Monitoring (CGM) Systems Market, By Region, 2023–2030 (USD Billion)
10. North America Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
11. North America Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
12. USA Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
13. USA Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
14. Canada Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
15. Canada Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
16. Mexico Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
17. Mexico Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
18. Europe Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
19. Europe Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
20. Germany Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
21. Germany Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
22. France Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
23. France Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
24. UK Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
25. UK Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
26. Italy Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
27. Italy Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
28. Spain Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
29. Spain Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
30. Asia Pacific Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
31. Asia Pacific Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
32. Japan Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
33. Japan Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
34. China Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
35. China Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
36. India Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
37. India Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
38. South America Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
39. South America Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
40. Brazil Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
41. Brazil Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
42. Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
43. Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
44. UAE Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
45. UAE Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)
46. South Africa Continuous Glucose Monitoring (CGM) Systems Market, By Component, 2023–2030 (USD Billion)
47. South Africa Continuous Glucose Monitoring (CGM) Systems Market, By End-User 2023–2030 (USD Billion)

List of Figures 

1. Global Continuous Glucose Monitoring (CGM) Systems Market Segmentation
2. Continuous Glucose Monitoring (CGM) Systems Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Continuous Glucose Monitoring (CGM) Systems Market Attractiveness Analysis By Component
9. Global Continuous Glucose Monitoring (CGM) Systems Market Attractiveness Analysis By End-User
10. Global Continuous Glucose Monitoring (CGM) Systems Market Attractiveness Analysis By Region
11. Global Continuous Glucose Monitoring (CGM) Systems Market: Dynamics
12. Global Continuous Glucose Monitoring (CGM) Systems Market Share By Component (2023 & 2030)
13. Global Continuous Glucose Monitoring (CGM) Systems Market Share By End-User (2023 & 2030)
14. Global Continuous Glucose Monitoring (CGM) Systems Market Share by Regions (2023 & 2030)
15. Global Continuous Glucose Monitoring (CGM) Systems Market Share by Company (2021)